Ahmed Bahi on Qatar’s Self-Infusion Program for Hemophilia Patients
Ahmed Bahi, Critical Care Pharmacist Specialist in Trauma Services at Hamad Medical Corporation, shared on LinkedIn:
”Exciting News from Qatar!
I’m thrilled to share the successful establishment of our self-infusion program for hemophilia patients, a collaborative effort between Qatar Foundation Health Group (QFHG) and the Hematology/Oncology team at Hamad Medical Corporation’s National Center for Cancer Care and Research (NCCCR).
This initiative included comprehensive didactic lectures and hands-on live stations, culminating in a knowledge assessment survey to ensure our patients feel empowered and informed.
A heartfelt thank you to everyone involved, especially:
– Dr. Osama Elhomsi
– Dr. Honar Cherif
– Dr. Liam Ferrnough
– Dr.Sheab Fared
– Dr.Amna Jameel
– Dr.Deena Mudawi
Your dedication and expertise made this program a reality, significantly improving the quality of life for hemophilia patients in our community.
Together, we are making strides toward better healthcare and patient empowerment!”
Stay updated with Hemostasis Today.
-
May 30, 2026, 10:27Sartaj Alam: CBC Analyzer – The Backbone of Modern Hematology Diagnostics
-
May 30, 2026, 10:17Factor X Deficiency – From Mild Bruising to Life Threatening Hemorrhage – ICHCC
-
May 30, 2026, 10:06Johann Morelle: Complement Inhibitors Are Reshaping Modern Nephrology
-
May 30, 2026, 09:49Flora Peyvandi: Exploring a Multidisciplinary Care Model for Hemophilia and Rare Diseases
-
May 30, 2026, 08:59Li-Chia Chen: Advancing Patient Care Through Pharmacist Innovation at KUTRRH
-
May 30, 2026, 08:58Ben Creagh-Brown: How Should HI-PEITHO Influence the Management of Intermediate-Risk Pulmonary Embolism?
-
May 30, 2026, 08:56Reidiel Suárez Borges: Understanding the INR in Anticoagulation Management
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products
-
May 29, 2026, 17:22Brian Schiro: Excited to Provide Guideline Based Care at the Aortic Center